News Articles

Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection

July 24, 2019

Proceeds Will Fund Pivotal Validation Study of Company’s Blood-based Test for the Screening of Colorectal Cancer Platform Has Potential for Use in Multiple Cancer Types and Enhanced Drug Development by Characterizing Tumor and Immune Signatures July 24, 2019 09:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Freenome, a biotechnology company that has pioneered the most…

Read More

CenExel Clinical Research Establishes Clinical Trial Centers Of Excellence Company

July 18, 2019

Unites Four of the Top US Clinical Research Facilities to Reduce Time and Cost for New Drug Development SALT LAKE CITY, July 18, 2019 /PRNewswire/ —  CenExel Clinical Research, Inc., (“CenExel” or the “Company”) announces the creation of their Centers of Excellence company, which unites four of the most experienced clinical research units in the country to design…

Read More

Sharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management

July 12, 2019

ATLANTA (July 12, 2019) – Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (NYSE: DGX) have formed a collaboration designed to improve digital health and disease management for a range of health care consumers. Sharecare has named Quest its preferred laboratory partner for its comprehensive digital…

Read More

Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection

July 11, 2019

Washington, D.C. (July 11, 2019) – BIO’s President and CEO Jim Greenwood issued the following statement after it was reported that the Trump administration is withdrawing its proposed rebate rule that would have required savings from drugmakers’ rebates be passed along to seniors enrolled in the Medicare drug benefit program: “The administration has abandoned one of the only…

Read More

Intent Solutions Joins University of Kentucky Program to Eliminate Hepatitis C in Appalachia

July 8, 2019

ATLANTA, Ga., July 8, 2019 /PRNewswire/ — Intent Solutions, an Atlanta-based company that provides technology to improve prescription drug safety and adherence, announced today that it is partnering with the University of Kentuckyin a $15 million federal grant program aimed at eliminating Hepatitis C in one eastern Kentucky county hardest hit by the disease.  Intent Solutions recently signed a contract with the University of Kentucky to…

Read More

New pharma boss: Next EU Commission should be clear on how to protect innovation

June 28, 2019

The next EU Commission should take a stronger position on innovation in the pharma sector, the new leader of the European Federation of Pharmaceutical Industries and Associations (EFPIA) told in an interview. “It will be important for the next European Commission to make an official statement on how they feel about innovation and how…

Read More